A loss of enzymatic processes within the body can increase a person's risk of bone fracture. This new insight was recently published in eLife by an international team of scientists and engineers led by Deepak Vashishth, the ...
Jan 5, 2021
0
10
University of South Carolina scientists are exploring ways to make nerve regeneration happen faster and more successfully.
Oct 15, 2020
0
42
Worldwide, cancer is the second leading cause of death—in 2018 alone, it claimed approximately 9.6 million lives, or one in six deaths. The development of cancer is incredibly complex and is controlled by an interplay of ...
Sep 11, 2020
0
6
In the first study to comprehensively track how different types of brain cells respond to the mutation that causes Huntington's disease (HD), MIT neuroscientists found that a significant cause of death for an especially afflicted ...
Jul 17, 2020
0
57
A study led by The University of Texas MD Anderson Cancer Center furthered understanding about mitochondria, the cell components known as the "powerhouse of the cell." Knowing more about the genome is crucial given that mitochondria ...
Feb 6, 2020
0
312
Researchers at the University of Liverpool have made a major breakthrough in the field of cell signalling.
Nov 4, 2019
0
5
Chronobiologists at Ludwig-Maximilians-Universität (LMU) in Munich, Germany, show in two articles in the journal Science how critical the sleep-wake cycle is for protein and phosphorylation dynamics in synapses to ultimately ...
Oct 11, 2019
0
154
A molecular process involved in the action of anti-leukemia drugs has been discovered at Université de Montréal's Institute for Research in Immunology and Cancer (IRIC). While calling into question a central tenet of oncology, ...
Jul 9, 2019
0
15
Patients with chronic myeloid leukemia can be treated with tyrosine kinase inhibitors. While these effective drugs lead to deep remission and prolonged survival, primitive leukemia stem cells resist elimination during the ...
Jun 11, 2019
0
13
When considering the role of the key immune molecule interleukin (IL)-17, the phrase "too much of a good thing" springs to mind. Because unlike some of its more sedate cytokine cousins which studiously direct the immune response ...
Jun 3, 2019
0
3
